Developer docs
API playgroundTry for free, no card

Search company profiles

Horiana

Full company profile

uuid004l7wa

Namestring
Horiana
Legal namestring
HORIANA
Websiteurl
horiana.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Horiana is a French health data consulting firm headquartered in Bordeaux with a regional office in San Francisco, operating as a SAS (Société par Actions Simplifiée) private company and positioned within the athagoras group. The company delivers professional services in biostatistics, epidemiology, evidence synthesis, and real-world evidence (RWE) generation for pharmaceutical and healthcare clients, with named enterprise engagements spanning Gilead Sciences, Pfizer, Bayer, Argenx, Nordic Pharma, Air Liquide, and Satelia.

Its core offerings cluster around three pillars: methodology and statistics (network meta-analyses, MAIC, cluster-randomization, predictive modeling for subgroup identification), External Comparator Arm / Synthetic Control Arm studies (propensity scores, instrumental variables, g-computation, quantitative benefit-risk assessment), and French nationwide database expertise across SNDS, PMSI, and ESND — a dataset covering 99% of the French population and gated by CESREES and CNIL approvals. The firm also designs multi-country RWE studies via a network of US and EU data partners, supports primary data collection (CRF, registries, ePRO), and runs Qualiopi-certified bespoke training programs. Educational content is published through Kézako webinars and RWE Vignettes on YouTube, in French with English subtitles.

Commercially, Horiana operates a sales-led, B2B professional services model. Engagements are project-based and quote-driven with no publicly disclosed pricing, and revenue is generated through direct consulting work rather than software or licensing. The company has 25 employees and no disclosed funding rounds, external investors, or revenue figures. Its distribution is direct enterprise sales into pharma and life sciences, supplemented by a content-driven inbound motion on LinkedIn and YouTube, with the San Francisco office extending reach into North American accounts.

Short descriptiontext

Horiana is a France-based health data consulting firm delivering biostatistics, epidemiology, and real-world evidence services to pharmaceutical and healthcare clients. It specializes in French nationwide database (SNDS/PMSI) studies, external comparator arms, and multi-country RWE, serving enterprises such as Gilead, Pfizer, and Bayer.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBordeaux, France
HQ citystring
Bordeaux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health data consulting, real-world evidence, biostatistics services, epidemiology research, pharmaceutical analytics
Industry2 codes
PRIMARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYBPAIAJAM
Health Data, Vital Statistics & Population Health Informatics
NAICS code2 codes
  • Other Scientific and Technical Consulting Services541690
  • Professional, Scientific, and Technical Services541
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Health Data Consulting
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Consulting Services
TypeProfessional Services
Description

Professional consulting services in health data analysis, biostatistics, and epidemiology. Revenue generated through project-based engagements with pharmaceutical companies and healthcare organizations.

horiana.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Horiana is a health data consulting firm that designs and executes biostatistics, epidemiology, evidence synthesis, external comparator arm studies, multi-country real-world studies, and primary and secondary data analyses for pharmaceutical, healthcare, and life sciences clients. It also provides bespoke Qualiopi-certified training in biostatistics and epidemiology. The firm differentiates through deep expertise in French nationwide claim databases (SNDS, PMSI, ESND) and advanced statistical methodologies such as cluster-randomization, MAIC, NMA, and synthetic control arms.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Horiana is a health data consulting firm offering a unified portfolio of analytical services rather than discrete software products. Core offerings include biostatistics and machine learning consulting, epidemiology study design and execution, evidence synthesis (network meta-analyses and MAIC), external comparator arm studies, multi-country real-world studies, primary data collection (CRF, registries, ePRO), secondary database studies, SNDS/PMSI expertise (French nationwide health databases), and bespoke training programs. These services are interconnected, with the company providing end-to-end support from study design through execution and analysis, leveraging French health database expertise as a key differentiator.

Product and service9 records
1Biostatistics & Machine Learning Consulting
CategoryHealth Data Consulting
Description

Methodology and biostatistics consulting encompassing cluster-randomization to mitigate selection bias, predictive modeling for subgroup identification, and other cutting-edge machine learning approaches applied to health data. Targeted at pharmaceutical and healthcare clients needing advanced statistical design and analysis.

2Epidemiology Studies
CategoryHealth Data Consulting
Description

Design and execution of descriptive, comparative, or evaluative epidemiological studies using standard designs or advanced methodologies such as self-controlled designs and complex multivariate models. Targeted at pharmaceutical companies and healthcare organizations requiring precise epidemiological evidence.

3Evidence Synthesis
CategoryHealth Data Consulting
Description

Synthesis of clinical evidence across studies using network meta-analyses (NMA) and Matching-Adjusted Indirect Comparison (MAIC). Targeted at pharmaceutical clients comparing multiple treatments for regulatory and market access purposes.

4External Comparator Arm Studies
CategoryHealth Data Consulting
Description

Orchestration of Synthetic Control Arm studies using optimal data sources and advanced methodologies including propensity scores, instrumental variables, g-computation, and quantitative benefit-risk assessment. Targeted at pharmaceutical sponsors needing comparator evidence for single-arm trials.

5Multi-Country Real-World Studies
CategoryHealth Data Consulting
Description

Design and execution of international real-world studies through a network of data partners in the US and EU committed to scientific rigor and regulatory compliance. Targeted at pharmaceutical and life sciences clients needing cross-border observational evidence.

6Primary Data Collection
CategoryHealth Data Consulting
Description

Design and analysis of prospectively collected data including Case Report Forms (CRF), disease-specific registries, and electronic Patient Reported Outcomes (ePRO) with full project support. Targeted at pharmaceutical and healthcare clients running prospective clinical or observational studies.

7Secondary Database Studies
CategoryHealth Data Consulting
Description

Selection and leverage of relevant secondary databases to conduct real-world studies, with support through regulatory processes from database selection to study execution. Targeted at pharmaceutical and healthcare clients needing retrospective database analyses.

8SNDS / PMSI Expertise
CategoryHealth Data Consulting
Description

Extensive proficiency in leveraging the French nationwide claim databases (SNDS, PMSI, ESND) for studies on disease burden, patient pathways, health care resource utilization, and drug or medical device efficacy and safety. Targeted at pharmaceutical and healthcare clients with regulatory-grade French real-world data needs.

9Bespoke Training Programs
CategoryTraining Services
Description

Customized training in biostatistics and epidemiology adapted to client needs, ranging from brief overviews to comprehensive advanced courses, with Qualiopi certification. Targeted at pharmaceutical, healthcare, and life sciences teams seeking capability building.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Horiana is part of athagoras group, indicating a strategic parent-subsidiary relationship within the health data consulting ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Emerging health data network operator providing access to hospital-based patient data for pharma RWE and clinical trial feasibility; comparable in using proprietary data assets to serve pharma RWE use cases, though with a different data-acquisition model.

TypeBroad incumbent
Description

Large global RWE and health economics consulting arm serving top-20 pharma with RWE, HEOR, and market access; broader portfolio but directly overlapping in NMA, MAIC, and real-world evidence generation for pharma.

3Heva
TypeDirect peer
Description

French health data and RWE consulting firm with deep SNDS/PMSI expertise serving pharma clients on epidemiology and health economics studies; directly comparable in methodology, customer base, and geographic anchoring.

TypeDirect peer
Description

Global biostatistics and advanced analytics CRO serving pharma with NMA, MAIC, and Bayesian methods; comparable in evidence-synthesis and biostatistics service offerings and pharma customer base, though at larger scale.

TypeBroad incumbent
Description

Global CRO and RWE leader with extensive real-world data assets and biostatistics services for pharma; broad incumbent offering overlap with Horiana's RWE and epidemiology service line at much larger scale.

TypeBroad incumbent
Description

Global CRO with PRA Health Sciences heritage providing RWE, HEOR, and biostatistics services to pharma; broad incumbent competing for the same enterprise RWE engagements as Horiana.

7Cegedim Health Data
TypeDirect peer
Description

French health data solutions provider with proprietary access to French claims and EHR databases (THIN, Longitudinal Patient Database), serving pharmaceutical RWE needs; highly comparable in SNDS-adjacent data access and pharma customer base.

TypeDirect peer
Description

French CRO specializing in pharmacoepidemiology, biostatistics, and clinical study management for pharma; comparable in offering portfolio, biostatistical methodology, and French pharma client base.

TypeDirect peer
Description

French health data consultancy providing epidemiology, biostatistics, and SNDS studies to pharmaceutical and public-health clients; directly comparable in scope, methodology, and target customers.

TypeDirect peer
Description

French health data and epidemiology consultancy offering RWE, market access, and SNDS-based studies to pharma and medtech clients; comparable in service portfolio, methodology focus, and French-anchored customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Horiana

Health Data Consultinghoriana.com

Horiana is a France-based health data consulting firm delivering biostatistics, epidemiology, and real-world evidence services to pharmaceutical and healthcare clients. It specializes in French nationwide database (SNDS/PMSI) studies, external comparator arms, and multi-country RWE, serving enterprises such as Gilead, Pfizer, and Bayer.

What Horiana does

Horiana is a French health data consulting firm headquartered in Bordeaux with a regional office in San Francisco, operating as a SAS (Société par Actions Simplifiée) private company and positioned within the athagoras group. The company delivers professional services in biostatistics, epidemiology, evidence synthesis, and real-world evidence (RWE) generation for pharmaceutical and healthcare clients, with named enterprise engagements spanning Gilead Sciences, Pfizer, Bayer, Argenx, Nordic Pharma, Air Liquide, and Satelia.

Its core offerings cluster around three pillars: methodology and statistics (network meta-analyses, MAIC, cluster-randomization, predictive modeling for subgroup identification), External Comparator Arm / Synthetic Control Arm studies (propensity scores, instrumental variables, g-computation, quantitative benefit-risk assessment), and French nationwide database expertise across SNDS, PMSI, and ESND — a dataset covering 99% of the French population and gated by CESREES and CNIL approvals. The firm also designs multi-country RWE studies via a network of US and EU data partners, supports primary data collection (CRF, registries, ePRO), and runs Qualiopi-certified bespoke training programs. Educational content is published through Kézako webinars and RWE Vignettes on YouTube, in French with English subtitles.

Commercially, Horiana operates a sales-led, B2B professional services model. Engagements are project-based and quote-driven with no publicly disclosed pricing, and revenue is generated through direct consulting work rather than software or licensing. The company has 25 employees and no disclosed funding rounds, external investors, or revenue figures. Its distribution is direct enterprise sales into pharma and life sciences, supplemented by a content-driven inbound motion on LinkedIn and YouTube, with the San Francisco office extending reach into North American accounts.

Horiana firmographics

Firmographics
Name
Horiana
Legal name
HORIANA
Website
https://horiana.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Horiana is a France-based health data consulting firm delivering biostatistics, epidemiology, and real-world evidence services to pharmaceutical and healthcare clients. It specializes in French nationwide database (SNDS/PMSI) studies, external comparator arms, and multi-country RWE, serving enterprises such as Gilead, Pfizer, and Bayer.
Ownership category
akta.pro rank

Horiana industry classification

Industry
Product category
Health Data Consulting
NAICS
Other Scientific and Technical Consulting Services (541690), Professional, Scientific, and Technical Services (541)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYBPAIAJAM
Health Data, Vital Statistics & Population Health Informatics

Keywords

  • Health data consulting
  • Real-world evidence
  • Biostatistics services
  • Epidemiology research
  • Pharmaceutical analytics

Where Horiana is headquartered

Location

Headquarters

HQ city
Bordeaux
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Horiana business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Others

Revenue model

  1. Consulting Services: Professional consulting services in health data analysis, biostatistics, and epidemiology. Revenue generated through project-based engagements with pharmaceutical companies and healthcare organizations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Horiana product offering

Product offering

Core offering

Horiana is a health data consulting firm that designs and executes biostatistics, epidemiology, evidence synthesis, external comparator arm studies, multi-country real-world studies, and primary and secondary data analyses for pharmaceutical, healthcare, and life sciences clients. It also provides bespoke Qualiopi-certified training in biostatistics and epidemiology. The firm differentiates through deep expertise in French nationwide claim databases (SNDS, PMSI, ESND) and advanced statistical methodologies such as cluster-randomization, MAIC, NMA, and synthetic control arms.

Product overview

Horiana is a health data consulting firm offering a unified portfolio of analytical services rather than discrete software products. Core offerings include biostatistics and machine learning consulting, epidemiology study design and execution, evidence synthesis (network meta-analyses and MAIC), external comparator arm studies, multi-country real-world studies, primary data collection (CRF, registries, ePRO), secondary database studies, SNDS/PMSI expertise (French nationwide health databases), and bespoke training programs. These services are interconnected, with the company providing end-to-end support from study design through execution and analysis, leveraging French health database expertise as a key differentiator.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biostatistics & Machine Learning Consulting Methodology and biostatistics consulting encompassing cluster-randomization to mitigate selection bias, predictive modeling for subgroup identification, and other cutting-edge machine learning approaches applied to health data. Targeted at pharmaceutical and healthcare clients needing advanced statistical design and analysis.
  • Epidemiology Studies Design and execution of descriptive, comparative, or evaluative epidemiological studies using standard designs or advanced methodologies such as self-controlled designs and complex multivariate models. Targeted at pharmaceutical companies and healthcare organizations requiring precise epidemiological evidence.
  • Evidence Synthesis Synthesis of clinical evidence across studies using network meta-analyses (NMA) and Matching-Adjusted Indirect Comparison (MAIC). Targeted at pharmaceutical clients comparing multiple treatments for regulatory and market access purposes.
  • External Comparator Arm Studies Orchestration of Synthetic Control Arm studies using optimal data sources and advanced methodologies including propensity scores, instrumental variables, g-computation, and quantitative benefit-risk assessment. Targeted at pharmaceutical sponsors needing comparator evidence for single-arm trials.
  • Multi-Country Real-World Studies Design and execution of international real-world studies through a network of data partners in the US and EU committed to scientific rigor and regulatory compliance. Targeted at pharmaceutical and life sciences clients needing cross-border observational evidence.
  • Primary Data Collection Design and analysis of prospectively collected data including Case Report Forms (CRF), disease-specific registries, and electronic Patient Reported Outcomes (ePRO) with full project support. Targeted at pharmaceutical and healthcare clients running prospective clinical or observational studies.
  • Secondary Database Studies Selection and leverage of relevant secondary databases to conduct real-world studies, with support through regulatory processes from database selection to study execution. Targeted at pharmaceutical and healthcare clients needing retrospective database analyses.
  • SNDS / PMSI Expertise Extensive proficiency in leveraging the French nationwide claim databases (SNDS, PMSI, ESND) for studies on disease burden, patient pathways, health care resource utilization, and drug or medical device efficacy and safety. Targeted at pharmaceutical and healthcare clients with regulatory-grade French real-world data needs.
  • Bespoke Training Programs Customized training in biostatistics and epidemiology adapted to client needs, ranging from brief overviews to comprehensive advanced courses, with Qualiopi certification. Targeted at pharmaceutical, healthcare, and life sciences teams seeking capability building.

Companies that use Horiana

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles2 records

Horiana technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Horiana partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • athagorascoreStrategic or Co-development PartnerHoriana is part of athagoras group, indicating a strategic parent-subsidiary relationship within the health data consulting ecosystem.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Horiana competitors and assessment

Company assessment

Emerging players

  • Clinerion: Emerging health data network operator providing access to hospital-based patient data for pharma RWE and clinical trial feasibility; comparable in using proprietary data assets to serve pharma RWE use cases, though with a different data-acquisition model.

Broad incumbents

  • Evidera (PPD/Thermo Fisher): Large global RWE and health economics consulting arm serving top-20 pharma with RWE, HEOR, and market access; broader portfolio but directly overlapping in NMA, MAIC, and real-world evidence generation for pharma.
  • IQVIA: Global CRO and RWE leader with extensive real-world data assets and biostatistics services for pharma; broad incumbent offering overlap with Horiana's RWE and epidemiology service line at much larger scale.
  • ICON plc: Global CRO with PRA Health Sciences heritage providing RWE, HEOR, and biostatistics services to pharma; broad incumbent competing for the same enterprise RWE engagements as Horiana.

Direct peers

  • Heva: French health data and RWE consulting firm with deep SNDS/PMSI expertise serving pharma clients on epidemiology and health economics studies; directly comparable in methodology, customer base, and geographic anchoring.
  • Cytel: Global biostatistics and advanced analytics CRO serving pharma with NMA, MAIC, and Bayesian methods; comparable in evidence-synthesis and biostatistics service offerings and pharma customer base, though at larger scale.
  • Cegedim Health Data: French health data solutions provider with proprietary access to French claims and EHR databases (THIN, Longitudinal Patient Database), serving pharmaceutical RWE needs; highly comparable in SNDS-adjacent data access and pharma customer base.
  • Kappa Santé: French CRO specializing in pharmacoepidemiology, biostatistics, and clinical study management for pharma; comparable in offering portfolio, biostatistical methodology, and French pharma client base.
  • Stève Consultants: French health data consultancy providing epidemiology, biostatistics, and SNDS studies to pharmaceutical and public-health clients; directly comparable in scope, methodology, and target customers.
  • OpenHealth: French health data and epidemiology consultancy offering RWE, market access, and SNDS-based studies to pharma and medtech clients; comparable in service portfolio, methodology focus, and French-anchored customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Horiana social profiles

Digital presence

Horiana compliance and trust

Trust signal

Compliance1 record

Horiana financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Horiana leadership team

Management profile

Number of profiles

Horiana funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Horiana M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Horiana

What does Horiana do?

Horiana is a health data consulting firm that designs and executes biostatistics, epidemiology, evidence synthesis, external comparator arm studies, multi-country real-world studies, and primary and secondary data analyses for pharmaceutical, healthcare, and life sciences clients. It also provides bespoke Qualiopi-certified training in biostatistics and epidemiology. The firm differentiates through deep expertise in French nationwide claim databases (SNDS, PMSI, ESND) and advanced statistical methodologies such as cluster-randomization, MAIC, NMA, and synthetic control arms.

Is Horiana a public or private company?

Horiana is a private company. It is classified as corporate owned and is currently operating.

When was Horiana founded?

Horiana was founded in -1. It employs 11 to 50 people.

Where is Horiana based?

Horiana is headquartered in Bordeaux, France, in the Europe region.

How does Horiana make money?

One revenue line is on record: consulting Services.

Who are Horiana's main competitors?

Clinerion is listed as an emerging player. Broad incumbents are Evidera (PPD/Thermo Fisher), IQVIA and ICON plc. Direct peers are Heva, Cytel, Cegedim Health Data, Kappa Santé, Stève Consultants and OpenHealth.

Does Horiana have an API?

No public API is recorded for Horiana.

What industry is Horiana in?

Horiana's product category is Health Data Consulting. Its primary akta.pro industry code is HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services, with a secondary code of BPAIAJAM, Health Data, Vital Statistics & Population Health Informatics. Its NAICS code is 541690 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales